REGN
Price
$493.22
Change
+$10.15 (+2.10%)
Updated
Jun 6 closing price
Capitalization
52.15B
52 days until earnings call
TECH
Price
$48.69
Change
+$0.38 (+0.79%)
Updated
Jun 6 closing price
Capitalization
7.57B
64 days until earnings call
Interact to see
Advertisement

REGN vs TECH

Header iconREGN vs TECH Comparison
Open Charts REGN vs TECHBanner chart's image
Regeneron Pharmaceuticals
Price$493.22
Change+$10.15 (+2.10%)
Volume$1.5M
Capitalization52.15B
Bio-Techne
Price$48.69
Change+$0.38 (+0.79%)
Volume$1.19M
Capitalization7.57B
REGN vs TECH Comparison Chart
Loading...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REGN vs. TECH commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a StrongBuy and TECH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (REGN: $591.85 vs. TECH: $47.93)
Brand notoriety: REGN: Notable vs. TECH: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REGN: 84% vs. TECH: 123%
Market capitalization -- REGN: $52.15B vs. TECH: $7.57B
REGN [@Biotechnology] is valued at $52.15B. TECH’s [@Biotechnology] market capitalization is $7.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 1 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • REGN’s FA Score: 1 green, 4 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, both REGN and TECH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 4 TA indicator(s) are bullish while TECH’s TA Score has 4 bullish TA indicator(s).

  • REGN’s TA Score: 4 bullish, 3 bearish.
  • TECH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both REGN and TECH are a good buy in the short-term.

Price Growth

REGN (@Biotechnology) experienced а -2.11% price change this week, while TECH (@Biotechnology) price change was +2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

REGN is expected to report earnings on Jul 31, 2025.

TECH is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($52.2B) has a higher market cap than TECH($7.57B). TECH has higher P/E ratio than REGN: TECH (58.17) vs REGN (12.28). REGN YTD gains are higher at: -16.684 vs. TECH (-33.270). TECH has less debt than REGN: TECH (395M) vs REGN (2.71B).
REGNTECHREGN / TECH
Capitalization52.2B7.57B690%
EBITDAN/AN/A-
Gain YTD-16.684-33.27050%
P/E Ratio12.2858.1721%
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt2.71B395M685%
FUNDAMENTALS RATINGS
REGN vs TECH: Fundamental Ratings
REGN
TECH
OUTLOOK RATING
1..100
416
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
5477
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
9364
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is in the same range as REGN (4). This means that TECH’s stock grew similarly to REGN’s over the last 12 months.

REGN's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as TECH (100). This means that REGN’s stock grew similarly to TECH’s over the last 12 months.

REGN's SMR Rating (54) in the Biotechnology industry is in the same range as TECH (77). This means that REGN’s stock grew similarly to TECH’s over the last 12 months.

REGN's Price Growth Rating (63) in the Biotechnology industry is in the same range as TECH (65). This means that REGN’s stock grew similarly to TECH’s over the last 12 months.

TECH's P/E Growth Rating (64) in the Biotechnology industry is in the same range as REGN (93). This means that TECH’s stock grew similarly to REGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
REGNTECH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
57%
Bullish Trend 12 days ago
70%
Momentum
ODDS (%)
Bullish Trend 12 days ago
59%
Bearish Trend 12 days ago
62%
MACD
ODDS (%)
Bullish Trend 12 days ago
61%
Bullish Trend 12 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
58%
Bearish Trend 12 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
66%
Bearish Trend 12 days ago
71%
Advances
ODDS (%)
Bullish Trend 20 days ago
61%
Bullish Trend 13 days ago
70%
Declines
ODDS (%)
Bearish Trend 18 days ago
54%
Bearish Trend 26 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
60%
Bearish Trend 12 days ago
68%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-1.89%
KRYS - REGN
46%
Loosely correlated
-2.44%
TECH - REGN
45%
Loosely correlated
-1.56%
VRTX - REGN
44%
Loosely correlated
-0.20%
CRNX - REGN
43%
Loosely correlated
+1.39%
ROIV - REGN
43%
Loosely correlated
-1.30%
More

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with ADPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
-1.56%
ADPT - TECH
48%
Loosely correlated
+0.11%
TRDA - TECH
47%
Loosely correlated
+0.91%
BEAM - TECH
47%
Loosely correlated
-0.88%
KYMR - TECH
47%
Loosely correlated
+2.35%
DNLI - TECH
46%
Loosely correlated
-1.29%
More